Literature DB >> 17370472

[Perivascular epithelioid cell tumor (PEComa) of the liver: a case report and review of the literature].

M Svajdler1, P Bohus, V Goc, V Tkácová.   

Abstract

Perivascular epithelioid cell tumor (PEComa) is rare entity and has been described only recently. By immunohistochemistry and genetics it belongs to the family of tumours which comprises angiomyolipoma, clear cell "sugar" tumor of lung, lymphangioleiomyomatosis and clear cell myomelanotic tumor of ligamentum falciforme/teres hepatis. We describe an unusual case of hepatic PEComa arising in a 55-year-old woman with previous history of glioblastoma. Histologically the tumor grew in expansive way, and was composed of clear and eosinophilic epithelioid cels, without vascular or lipomatous component characteristic of angiomyolipoma. There was mild nuclear pleomorphism, sporadic mitotic activity and haemorrhage without necrosis. On immunohistochemistry, the tumor was HMB-45+50, Melan-A and smooth muscle actin positive. Tyrosinase, S-100 protein, cytokeratin coctail, EMA, vimentin, muscle specific actin, CD10, TTF-1, hepatocyte, desmin and cyclin D1 were negative. Sporadic nuclear p53 positivity was seen. The main differential diagnosis of hepatic PEComa includes clear cell variant of liver cell adenoma and hepatocellular carcinoma, metastases of various clear cell carcinomas and metastasis of malignant melanoma. In respect of uncertain biologic potential of PEComa, long term follow up is indicated.

Entities:  

Mesh:

Year:  2007        PMID: 17370472

Source DB:  PubMed          Journal:  Cesk Patol        ISSN: 1210-7875


  6 in total

Review 1.  Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review.

Authors:  Toshiya Maebayashi; Katsumi Abe; Takuya Aizawa; Masakuni Sakaguchi; Naoya Ishibashi; Osamu Abe; Tadatoshi Takayama; Hisashi Nakayama; Shunichi Matsuoka; Kazushige Nirei; Hitomi Nakamura; Masahiro Ogawa; Masahiko Sugitani
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

2.  Adoptive T-Cell Transfer to Treat Lymphangioleiomyomatosis.

Authors:  Fei Han; Emilia R Dellacecca; Levi W Barse; Cormac Cosgrove; Steven W Henning; Christian M Ankney; Dinesh Jaishankar; Alexander Yemelyanov; Vera P Krymskaya; Daniel F Dilling; I Caroline Le Poole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

Review 3.  Primary perivascular epithelioid cell tumor (PEComa) of the liver: report of a case.

Authors:  Janusz M Strzelczyk; Adam Durczynski; Dariusz Szymanski; Maciej Jablkowski; Daniela Dworniak; Stanislaw Sporny
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

4.  Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.

Authors:  Jared Klarquist; Allison Barfuss; Sridhar Kandala; Mary J Reust; Ruedi K Braun; Jennifer Hu; Daniel F Dilling; Mark D McKee; Raymond E Boissy; Robert B Love; Michael I Nishimura; I Caroline Le Poole
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

5.  PEComa: A Perivascular Epithelioid Cell Tumor in the Liver-A Case Report and Review of the Literature.

Authors:  Faseeh Khaja; Allison Carilli; Said Baidas; Aravindhan Sriharan; Shanedelle Norford
Journal:  Case Rep Med       Date:  2013-12-29

Review 6.  Primary perivascular epithelioid cell tumor of the liver: new case report and literature review.

Authors:  Hassania Ameurtesse; Laïla Chbani; Amal Bennani; Imane Toughrai; Nouhad Beggui; Imane Kamaoui; Hinde Elfatemi; Taoufik Harmouch; Afaf Amarti
Journal:  Diagn Pathol       Date:  2014-07-17       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.